Even if GLP-1 medications slightly increased medullary thyroid cancer risk, the baseline rate is so low that the absolute risk would remain minimal
Potential Adverse Effects and Hazards Common side effects: Nausea and vomiting Diarrhea or constipation Stomach pain or bloating Reduced appetite Serious risks (rare): Pancreatitis Gallbladder disease Kidney problems Allergic reactions Cautions: Contraindicated in case of the following personal history: medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 Do not forget to discuss Semaglutide contraindications with your physician
Month 1: Initial Results (0.25 mg dose) Average weight loss: 1-2% of body weight (2-4 pounds for a 200-pound person) Your first month on semaglutide serves primarily as an initiation period
It is important to note that restoration of fertility may occur unexpectedly in women with PCOS or obesity-related anovulation who begin losing weight on Ozempic
Its actually better not to lose weight too quickly this can lead to health issues like gallstones, and may also not be sustainable over the long term
DIO-MASH study In the efficacy study, animals were administered vehicle or semaglutide 123 g kg 1 ( n = 16) daily for 8, 16 or 24 weeks
